Brown Advisory Inc. Grows Stock Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

Brown Advisory Inc. raised its position in OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 6.2% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,628,747 shares of the company's stock after buying an additional 94,719 shares during the period. Brown Advisory Inc. owned about 6.71% of OrthoPediatrics worth $40,116,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Bank of New York Mellon Corp increased its stake in shares of OrthoPediatrics by 3.8% in the 4th quarter. Bank of New York Mellon Corp now owns 57,710 shares of the company's stock valued at $1,338,000 after purchasing an additional 2,099 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in OrthoPediatrics by 2.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 136,234 shares of the company's stock valued at $3,158,000 after purchasing an additional 3,800 shares during the period. HighTower Advisors LLC purchased a new stake in shares of OrthoPediatrics in the fourth quarter valued at approximately $268,000. American Century Companies Inc. raised its stake in shares of OrthoPediatrics by 13.2% during the 4th quarter. American Century Companies Inc. now owns 26,410 shares of the company's stock worth $612,000 after buying an additional 3,072 shares during the period. Finally, KLP Kapitalforvaltning AS purchased a new position in shares of OrthoPediatrics during the 4th quarter valued at approximately $79,000. Institutional investors and hedge funds own 69.05% of the company's stock.

OrthoPediatrics Price Performance

KIDS stock traded up $0.38 during mid-day trading on Wednesday, reaching $22.06. The company's stock had a trading volume of 98,722 shares, compared to its average volume of 198,972. The company has a current ratio of 6.19, a quick ratio of 2.99 and a debt-to-equity ratio of 0.21. The company's 50 day moving average is $21.49 and its two-hundred day moving average is $23.05. OrthoPediatrics Corp. has a fifty-two week low of $19.52 and a fifty-two week high of $35.99. The stock has a market cap of $535.77 million, a PE ratio of -12.61 and a beta of 1.10.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported ($0.39) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.13). The company had revenue of $52.41 million during the quarter, compared to analyst estimates of $51.68 million. OrthoPediatrics had a negative net margin of 19.15% and a negative return on equity of 7.03%. Equities research analysts expect that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Lake Street Capital initiated coverage on shares of OrthoPediatrics in a report on Monday, April 7th. They issued a "buy" rating and a $37.00 price target for the company. Needham & Company LLC reissued a "buy" rating and set a $42.00 target price on shares of OrthoPediatrics in a research note on Thursday, May 8th. Wall Street Zen raised shares of OrthoPediatrics from a "sell" rating to a "hold" rating in a research note on Friday, June 27th. Piper Sandler lowered their price objective on OrthoPediatrics from $40.00 to $30.00 and set an "overweight" rating on the stock in a report on Thursday, May 8th. Finally, Truist Financial reduced their target price on OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating for the company in a report on Friday, April 11th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $35.83.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.